User:Fareforward/sandbox

DRAFT PAGE

Community Research Initiative is

HDAP
Since 1990, Community Research Initiative has administered the Massachusetts HIV Drug Assistance Program (HDAP). HDAP is an AIDS Drug Assistance Program and is a program of the HIV/AIDS Office of the Massachusetts Department of Public Health.

In order to be eligible for HDAP, an individual must be HIV-positive and living in Massachusetts. To enroll, an individual must also meet income eligibility guidelines, set at a level that recognizes both the high cost and number of HIV-related medications an individual with HIV/AIDS may need, as well as the high cost of living in Massachusetts. HDAP serves over 6,000 individuals.

In 2000, CRI implemented the Comprehensive Health Insurance Initiative (CHII). CHII is a program of HDAP that can assistant with paying the cost of health insurance premiums and drug co-payments for individuals living with HIV/AIDS who do not have health insurance or who already have insurance but can no longer afford to pay it.

HDAP also provides reimbursement to healthcare sites for the cost of viral resistance testing and nPEP, a post-exposure prophylaxis program which provides drug therapy designed to reduce the possibility of infection with HIV after a known high-risk exposure has occurred.

Dr. Calvin Cohen
Calvin J. Cohen, M.D., M.Sc., is the Director of Research at Community Research Initiative of New England. In addition, he is a Clinical Instructor at Harvard Medical School in Boston, Staff Physician at Brigham and Women's Hospital, and Research Director at Harvard Vanguard Medical Associates.

Dr. Cohen earned his B.A. degree at Cornell University, his M.D. at the Albert Einstein College of Medicine, and his M.Sc. at the Harvard School of Public Health. After graduating, he completed his internship and residency in medicine at Beth Israel Hospital in Boston. He also served as Chief Medical Resident at the Veterans Administration Hospital in Brockton, Massachusetts, under the auspices of Harvard Medical School. His fellowship in general internal medicine was completed at Harvard Medical School.

Dr. Cohen's research interests include the study and antiviral treatment of HIV/AIDS and related topics. He has served as co-chair of the Scientific Advisory Committee of the AmFAR Community-Based Clinical Trial Network and was a co-investigator of the Harvard AIDS Clinical Trial Unit. In addition to his clinical and research roles, Dr. Cohen is currently a co-principal investigator of the New England AIDS Education and Training Center, and is a member of the Executive Committee of INSIGHT, an NIH-supported network of clinician-researchers.